researchMedicinesilicosmall molecule

AI Convergence: Small Molecule Discovery Summit 2026

Name: AI Convergence: Small Molecule Discovery Summit 2026
Start: 2026-03-20T09:00:00+00:00
End: 2026-03-20T18:00:00+00:00
Location: Boston, United States

20 mar 202609:00 AM-06:00 PM (expected)Boston, United StatesDelegates Participantes

Descrição

The AI Convergence: Small Molecule Discovery Summit is an essential gathering for industry leaders and innovators at the forefront of AI and medicinal chemistry. This summit emphasizes the transformative potential of AI and machine learning (AI/ML) in accelerating the design and optimization of small molecules aimed at challenging drug targets.

Destaques

22 world-class AI/ML-guided small molecule discovery speakers. 2 days of exclusive content addressing AI/ML methods, applications, tool convergence, and confidence. Unmatched networking and strategic partnering opportunities. Focused industry-led community of top techbio, pharma, and biotech companies. Explore AI/ML applications that elucidate undruggable target protein folding. Leverage AI/ML-enabled virtual screening to tap into unexplored chemical space. Use generative molecular design for molecular glues, covalent inhibitors, and degraders. Optimize ADME-T and address data input and federated learning platform opportunities. Join industry leaders such as Insilico Medicine, PsiThera, OpenADMET, Sanofi, and Novo Nordisk. Discover the convergence of state-of-the-art AI/ML tools with existing approaches to ignite future AI/ML-enabled small molecule discovery.